Overview
Paul Martin is a Pediatric Hematologist Oncology provider in Chapel Hill, North Carolina. Dr. Martin is rated as an Experienced provider by MediFind in the treatment of Hemolytic Anemia. His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Leukemia, Infantile Neutropenia, Graft Versus Host Disease (GvHD), and Bone Marrow Transplant.
His clinical research consists of co-authoring 66 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Hemolytic Anemia.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- POS
Locations
Additional Areas of Focus
Dr. Martin has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Duke Children's Health Center Hematology/Oncology Clinic
I treat children with cancer and blood disorders, such as anemia and sickle cell disease. When families come in, there is understandably a huge amount of anxiety. I try to spend a lot of time with them and discuss what we know, what we need to find out, and how we plan to care for their children. My goal is to make it the least scary as possible for both the children and the parents/caregivers while providing the best care. Even in the setting of severe illness, interacting with children is uplifting and extremely rewarding. Children truly demonstrate the resilience of the human spirit. What I love most about my job is having relationships with children and seeing them grow; it is a wonderful experience. Dr. Rothman is rated as a Distinguished provider by MediFind in the treatment of Hemolytic Anemia. Her top areas of expertise are Pyruvate Kinase Deficiency, Anemia, Hemolytic Anemia, Congenital Hemolytic Anemia, and Splenectomy.
Rupa Redding is a Pediatric Hematologist Oncology provider in Chapel Hill, North Carolina. Dr. Redding is rated as an Advanced provider by MediFind in the treatment of Hemolytic Anemia. Her top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, and Hemolytic Anemia.
University Of North Carolina At Chapel Hill
Alexandra Borst is a Pediatric Hematologist Oncology provider in Chapel Hill, North Carolina. Dr. Borst is rated as an Advanced provider by MediFind in the treatment of Hemolytic Anemia. Her top areas of expertise are Arteriovenous Malformation, Sickle Cell Disease, Hemoglobin SC Disease, Thalassemia, and Spinal Fusion.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Lymphoblastic Leukemia (ALL)
- Bone Marrow TransplantDr. Martin isAdvanced. Learn about Bone Marrow Transplant.
- LeukemiaDr. Martin isAdvanced. Learn about Leukemia.
- Experienced
- Adult T-Cell LeukemiaDr. Martin isExperienced. Learn about Adult T-Cell Leukemia.
- AnemiaDr. Martin isExperienced. Learn about Anemia.
- Aplastic AnemiaDr. Martin isExperienced. Learn about Aplastic Anemia.
- Childhood Acute Myeloid LeukemiaDr. Martin isExperienced. Learn about Childhood Acute Myeloid Leukemia.
- Congenital Hemolytic AnemiaDr. Martin isExperienced. Learn about Congenital Hemolytic Anemia.
- Graft Versus Host Disease (GvHD)Dr. Martin isExperienced. Learn about Graft Versus Host Disease (GvHD).